<ul data-eligibleForWebStory="false"><li>Synfini Inc. secures $8.9M funding to accelerate AI-powered drug discovery.</li><li>The startup combines neuro-symbolic AI with physical and virtual chemistry for innovation.</li><li>Synfini's AI Cloud Foundry platform speeds up small molecule discovery and reduces costs.</li><li>The company, spun out from SRI International, plans to expand operations and partnerships.</li><li>Investors see potential in Synfini's advanced medicinal chemistry AI platform for drug discovery.</li></ul>

Synfini gets $8.9M to accelerate drug discovery with AI

Discover more